PC-D-F07

N/A

Report date: 2025/06/11 11:08:47
NME

Base Information

Drug NamePC-D-F07
Drug Alias Namefluorescent tricyclic chromenone inhibitor (Wistar Institute/University of South Florida)PC-D-F07D-F07
ClassificationSmall molecules
Mechanisms of ActionAnticancer protein kinase inhibitorsSerine/threonine-protein kinase/endoribonuclease IRE1 inhibitors
TargetsSerine/threonine-protein kinase/endoribonuclease IRE1
Therapy Area/IndicationsLeukemia, Lymphocytic, Chronic, B-CellNeoplasmsBurkitt Lymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe Wistar Institute Of Anatomy And Biology
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of South FloridaThe Wistar Institute Of Anatomy And Biology
Inactive CompaniesN/A
Active IndicationsLeukemia, Lymphocytic, Chronic, B-CellBurkitt Lymphoma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A